Literature DB >> 29502481

A Successful Pharmacist-Based Quality Initiative to Reduce Inappropriate Stress Ulcer Prophylaxis Use in an Academic Medical Intensive Care Unit.

Umair Masood1, Anuj Sharma1, Zabeer Bhatti1, Jessica Carroll1, Amit Bhardwaj1, Devamohan Sivalingam1, Amit S Dhamoon1.   

Abstract

Stress ulcer prophylaxis (SUP) is often inappropriately utilized, particularly in critically ill patients. The objective of this study is to find an effective way of reducing inappropriate SUP use in an academic medical intensive care unit (ICU). Medical ICU patients receiving SUP were identified over a 1-month period, and their charts were reviewed to determine whether American Society of Health-System Pharmacists guidelines were followed. Inappropriate usage was calculated as inappropriate patient-days and converted to incidence per 100 patient-days. Two interventions were implemented: (1) Pharmacists reviewed indications for SUP on each patient during daily team rounds and daily medication reconciliation and (2) residents rotating on ICU services were educated on a bimonthly basis. Postintervention data were obtained in a similar fashion. Prior to intervention, the incidence of inappropriate SUP usage was calculated to be 26.75 per 100 patient-days (n = 1099 total patient-days). Total cost attributable to the inappropriate use was $2433. Post intervention, we were able to decrease the inappropriate incidence of SUP usage to 7.14 per 100 patient-days (n = 1149 total patient-days). In addition, total cost of inappropriate use was reduced to $239.80. Our study highlights an effective multidisciplinary approach to reduce the inappropriate use of SUP in an academic medical ICU. We were able to reduce the incidence of inappropriate use of SUP by 73.31% ( P < .001). Furthermore, we were able to decrease the costs by approximately $2200/month.

Entities:  

Keywords:  inappropriate; pharmacist; proton pump inhibitors; quality; stress ulcer prophylaxis

Mesh:

Substances:

Year:  2018        PMID: 29502481      PMCID: PMC5843103          DOI: 10.1177/0046958018759116

Source DB:  PubMed          Journal:  Inquiry        ISSN: 0046-9580            Impact factor:   1.730


  27 in total

1.  Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.

Authors:  Chun Shing Kwok; Aaron Kobina Arthur; Chukwudubem Ifeanyichukwu Anibueze; Sonal Singh; Rodrigo Cavallazzi; Yoon Kong Loke
Journal:  Am J Gastroenterol       Date:  2012-04-24       Impact factor: 10.864

2.  Overutilization of proton-pump inhibitors: what the clinician needs to know.

Authors:  Joel J Heidelbaugh; Andrea H Kim; Robert Chang; Paul C Walker
Journal:  Therap Adv Gastroenterol       Date:  2012-07       Impact factor: 4.409

Review 3.  Update on stress ulcer prophylaxis in critically ill patients.

Authors:  Mitchell J Spirt; Sandra Stanley
Journal:  Crit Care Nurse       Date:  2006-02       Impact factor: 1.708

4.  Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study.

Authors:  Sinem Ezgi Gulmez; Anette Holm; Henrik Frederiksen; Thøger Gorm Jensen; Court Pedersen; Jesper Hallas
Journal:  Arch Intern Med       Date:  2007-05-14

5.  Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.

Authors:  Yan Xie; Benjamin Bowe; Tingting Li; Hong Xian; Sumitra Balasubramanian; Ziyad Al-Aly
Journal:  J Am Soc Nephrol       Date:  2016-04-14       Impact factor: 10.121

6.  Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis.

Authors:  Alan N Barkun; Marc Bardou; C Q D Pham; Myriam Martel
Journal:  Am J Gastroenterol       Date:  2012-01-31       Impact factor: 10.864

7.  Brief report: Reducing inappropriate usage of stress ulcer prophylaxis among internal medicine residents. A practice-based educational intervention.

Authors:  Joshua D Liberman; Chad T Whelan
Journal:  J Gen Intern Med       Date:  2006-05       Impact factor: 5.128

8.  Acute interstitial nephritis due to proton pump inhibitors.

Authors:  K Sampathkumar; R Ramalingam; A Prabakar; A Abraham
Journal:  Indian J Nephrol       Date:  2013-07

9.  Proton-pump inhibitor use and the risk for community-acquired pneumonia.

Authors:  Monika Sarkar; Sean Hennessy; Yu-Xiao Yang
Journal:  Ann Intern Med       Date:  2008-09-16       Impact factor: 25.391

10.  The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients.

Authors:  D J Cook; L E Griffith; S D Walter; G H Guyatt; M O Meade; D K Heyland; A Kirby; M Tryba
Journal:  Crit Care       Date:  2001-10-05       Impact factor: 9.097

View more
  5 in total

1.  Impact of a multidisciplinary quality improvement initiative to reduce inappropriate usage of stress ulcer prophylaxis in hospitalized patients.

Authors:  Yeo Jin Choi; Joohyun Sim; Yun Tae Jung; Sooyoung Shin
Journal:  Br J Clin Pharmacol       Date:  2020-01-22       Impact factor: 4.335

2.  Impact of Stress Ulcer Prophylaxis Discontinuation Guidance in Mechanically Ventilated, Critically Ill Patients: A Pre-Post Cohort Study.

Authors:  Christopher A Jones; Kevin D Betthauser; Bryan D Lizza; Paul A Juang; Scott T Micek; Marin H Kollef
Journal:  Hosp Pharm       Date:  2021-12-07

3.  Appropriateness and Associated Factors of Stress Ulcer Prophylaxis for Surgical Inpatients of Orthopedics Department in a Tertiary Hospital: A Cross-Sectional Study.

Authors:  Haiyan Li; Ning Li; Xiaoni Jia; Yuyao Zhai; Xiaorong Xue; Yi Qiao
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

4.  Assessment of pharmacologic prophylaxis use against stress ulcer in the medical wards of University of Gondar Hospital.

Authors:  Boressa Adugna Horsa; Yohanes Ayele; Mohammed Biset Ayalew
Journal:  SAGE Open Med       Date:  2019-02-02

5.  Adherence to a stress ulcer prophylaxis protocol by critically ill patients: a prospective cohort study.

Authors:  Yuri de Albuquerque Pessoa Dos Santos; Mauricio Staib Younes-Ibrahim; Lucas Lonardoni Crozatti; Dante Raglione; Luis Carlos Maia Cardozo Junior; Bruno Adler Maccagnan Pinheiro Besen; Leandro Utino Taniguchi; Marcelo Park; Pedro Vitale Mendes
Journal:  Rev Bras Ter Intensiva       Date:  2020-05-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.